Further validation through immunohistochemical analysis of tumor tissues from our independent cohort of 176 HCC patients in Guangdong, China, confirmed significantly higher HHLA2 protein levels in tumors compared to adjacent non-tumor tissues (Supplemental Fig. 1E). The gene discussed is HHLA2; the disease is neoplasm.